International Journal of Cardiovascular Research is a peer-reviewed scholarly journal and aims to publish the most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of cardiology and making them available online freely without any restrictions or any other subscriptions to researchers worldwide.
International Journal of Cardiovascular Research focuses on the topics include Heart diseases, Cardiovascular medicine, Echocardiography, Cardiac electrophysiology, Neuro cardiology, Cardiac Anesthesiology, Disorders of heart, treatment, pediatric cardiology, Interventional Cardiology and Hypercholesterolemia.
The journal is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of International Journal of Cardiovascular Research or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.
Specificity of the Cardiocerebral-Event Reductions in the Kyoto Heart and Jikei Heart Study
The Kyoto Heart Study was a prospective randomized open blinded end-point (PROBE)-design trial, in which 3031 Japanese patients (mean, 66 years) with uncontrolled hypertension were randomized to either valsartan add-on or non-angiotensin receptor blocker (ARB) treatment.
Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage
This is an overview of literature data on ischemia-modified albumin (IMA) and its potential as a marker of myocardium and skeletal muscle damage. Characteristics and properties of IMA are considered. IMA can be used as a nonspecific variable of ischemic conditions but IMA fails to differentiate between ischemic tissues. As a marker of ischemic conditions IMA may be used in combinations with other markers.
Left Atrial Myxoma Associated with Advanced Atrioventricular Block in a Very Elderly Woman
Primary cardiac tumors are rare and only 10% of them are malignant. Nearly 80% of benign forms are myxomas that usually develop in the atria, 75% originating in the left atrium and 15-20% in the right atrium.